When Salvatore Maranzano organized the five Italian Mafia families in NYC in 1931, he succeeded largely because each family agreed to operate within their specified geographic location.
As long as each family stayed within their own turf, they got along reasonably well. Each family doing their own business and making their own profits. But, of course, sometimes they crossed the lines. When they did, people got hurt.
I saw the following headline: “Food companies are freaking out about Ozempic.”
The gist — food (and healthcare) companies are concerned and preparing business mitigation plans because people may stop spending as much on snacking and healthcare services. Of course, the street runs on foreshadowing, rumors, and fear. This is the food and healthcare companies getting out in front of the news with their own PR — this is the actual mitigation. “We have a plan.”
But the pharma brands in on the GLP-1 wave couldn’t be happier. If you own stock in them, you’re probably happy, also. Novo Nordisk (Ozempic) stock has doubled over the last year. Like opioids before it, GLP-1 drugs (Ozempic, Wegovy, etc) are already overprescribed.
When one entity starts to gain or thrive, it’s often at the expense of another.
A food company’s number one purpose isn’t to make you healthy. It’s to make money for its owners/investors/stockholders.
A healthcare or insurance company’s number one purpose isn’t to make you healthy. It’s to make money for its owners/investors/stockholders.
A pharmaceutical company’s number one purpose isn’t to make you healthy. It’s to make money for its owners/investors/stockholders.
When you engage in a turf war, somebody’s gonna get hurt.
